Regional Biocontainment Laboratories Facility and Building System Upgrades Support
Regional Biocontainment Laboratories Facility and Building System Upgrades Support
批准号:
10392181
负责人:
Colin S. Duckett
金额:
$332.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-23 至 2025-02-28
关键词:
AddressAirAnimal ExperimentationAnimal ModelBasic ScienceBiological AssayCell SeparationCellsCertificationChemicalsCommunicable DiseasesComputer SecurityComputer softwareContainmentContractorContractsCore FacilityCustomDiagnosticDisease OutbreaksEmerging Communicable DiseasesEngineeringEquipmentFacility Design and ConstructionFacility DesignsFundingGoalsGrantInfectionInfectious Diseases ResearchInfrastructureInternationalLaboratoriesLeadershipMaintenanceModernizationMonitorMusPerformancePharmaceutical PreparationsRecoveryResearchResearch PersonnelResourcesSecurityService provisionServicesSolidSystemTestingTimeTrustUnited States National Institutes of HealthUniversitiesVaccinesVendoragedbiocontainment facilitybiodefensecostdesigndesign and constructioninnovationlaboratory facilitymedical schoolsoperationpressurepreventprogramsrepaired
中文摘要
项目摘要/摘要:
杜克地区生物遏制实验室(RBL)是由国家研究所提供资金建造的
卫生部(NIH)支持必要的基础研究,以开发药物、诊断和疫苗
新出现/再次出现的感染和生物防御。最先进的生物遏制设施,旨在
支持实验室和小动物研究,于2007年在杜克完全委托并开放运营
北卡罗来纳州达勒姆的大学医学院校区。杜克大学RBL基金支持赠款/合同资助
研究人员还提供生物遏制实验室、创新的宿主监测分析和小动物模型
在收回成本的基础上通过核心服务中心单位。十四年的使用和时间使
杜克大学RBL的一些设施、系统和关键核心研究设备陈旧或需要维修,
更替或现代化。我们已经确定了该设施现有体检的六个严重缺陷
限制生物安全、安保或威胁其提供的服务和与研究相关的服务的基础设施
它所支持的活动。我们将在我们的三个具体目标中解决这些不足:1)使建筑空气现代化
控制系统-升级过时的BSL3/ABSL3建筑控制系统、压力监测器和软件。
重新平衡、测试、验证和重新认证所有受影响的BSL3/ABSL3空间;2)使生物安全和安保现代化
系统-更换BSL2/BSL3/ABSL3实验室中老化/损坏的生物安全柜。维修和升级
BSL3化学废水处理系统的组件。更换损坏或陈旧的闭合电路
安全摄像头、布线以及与建筑物安全控制系统的集成;以及3)现代化研究
资源-更换BSL3细胞中过时的高含物细胞分类器和定制的BioProtect头罩
分拣核心设施。升级Allentown生物隔离鼠笼机架上的鼓风机控制模块
在ABSL3中。这些目标将由一个高度集成的项目管理团队来实现,该团队具有
坚实的机构支持和值得信赖的承包商/供应商是原始设计和施工的一部分
和/或已成为设施的持续维护、维修和认证的一部分
过去的14年里。
英文摘要
Project Summary/Abstract:
The Duke Regional Biocontainment Laboratory (RBL) was constructed with funding from the National Institutes
of Health (NIH) to support basic research necessary to develop drugs, diagnostics, and vaccines for
emerging/reemerging infections and biodefense. The state-of-the-art biocontainment facility, designed to
support lab and small animal research, was fully commissioned and opened for operation in 2007 on the Duke
University Medical School Campus in Durham, NC. The Duke RBL facility supports grant/contract-funded
investigators and also provides biocontainment labs, innovative host monitoring assays and small animal models
through Core Service Center Units on a cost recovery basis. Fourteen years of use and time have rendered
some of the Duke RBL facilities, systems and critical core research equipment obsolete, or in need of repair,
replacement or modernization. We have identified six critical deficiencies of the facility’s existing physical
infrastructure that limit biosafety, security or threaten the provision of services it offers and research-related
activities it supports. We will address these deficiencies in our three Specific Aims: 1) Modernize Building Air
Control Systems – Upgrade obsolete BSL3/ABSL3 building controls systems, pressure monitors and software.
Rebalance, test, validate and re-certify all impacted BSL3/ABSL3 space; 2) Modernize Biosafety and Security
Systems - Replace aged/damaged biosafety cabinets in BSL2/BSL3/ABSL3 laboratories. Repair and upgrade
components of the BSL3 chemical effluent treatment system. Replace damaged or obsolete closed circuit
security cameras, cabling and integration with building security control systems; and 3) Modernize Research
Resources – Replace the obsolete high-containment cell sorter and custom Bioprotect hood in the BSL3 Cell
Sorting Core facility. Upgrade the blower control modules on the Allentown Biocontainment mouse cage racks
in the ABSL3. These Aims/Goals will be accomplished by a highly integrated project management team with
solid institutional support and trusted contractors/vendors that were part of the original design and construction
of the facility and/or have been part of the continuous maintenance, repair and certification of the facility for the
past 14 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resources and Workforce Development for the Regional Biocontainment Laboratories
-
批准号:10791947
-
项目类别:
-
资助金额:$288.3万
-
财政年份:2023
-
负责人:Colin S. Duckett
-
依托单位:
Core 1: Facility Management, Maintenance and Operations Core
-
批准号:10791948
-
项目类别:
-
资助金额:$93.32万
-
财政年份:2023
-
负责人:Colin S. Duckett
-
依托单位:
Core 3: Biocontainment Research Support Services Core
-
批准号:10791950
-
项目类别:
-
资助金额:$102.95万
-
财政年份:2023
-
负责人:Colin S. Duckett
-
依托单位:
Administrative supplement to Duke G20 award
-
批准号:10626469
-
项目类别:
-
资助金额:$326.48万
-
财政年份:2021
-
负责人:Colin S. Duckett
-
依托单位:
Signal Transduction Pathways in CD30-positive Lymphomas
-
批准号:8109947
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2010
-
负责人:Colin S. Duckett
-
依托单位:
Signal Transduction Pathways in CD30-positive Lymphomas
-
批准号:8403989
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2010
-
负责人:Colin S. Duckett
-
依托单位:
Signal Transduction Pathways in CD30-positive Lymphomas
-
批准号:7984372
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2010
-
负责人:Colin S. Duckett
-
依托单位:
Signal Transduction Pathways in CD30-positive Lymphomas
-
批准号:8589578
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2010
-
负责人:Colin S. Duckett
-
依托单位:
Signal Transduction Pathways in CD30-positive Lymphomas
-
批准号:8204634
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2010
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:7917092
-
项目类别:
-
资助金额:$6.76万
-
财政年份:2009
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:7588832
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2005
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:6916132
-
项目类别:
-
资助金额:$26.27万
-
财政年份:2005
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:7195091
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2005
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:7025023
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2005
-
负责人:Colin S. Duckett
-
依托单位:
Control of Apoptosis and Signaling by XIAP
-
批准号:7390335
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2005
-
负责人:Colin S. Duckett
-
依托单位:
Characterization of the Inhibitor of Apoptosis (IAP) Gen
-
批准号:6758378
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Colin S. Duckett
-
依托单位:
Characterization of Apoptosis Gene Family Inhibitor
-
批准号:6420839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Colin S. Duckett
-
依托单位:
Induction of Apoptosis in Lymphoma Cells by Activation o
-
批准号:6758290
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Colin S. Duckett
-
依托单位:
Induction of Apoptosis in Lymphoma Cells by Activation of CD30
-
批准号:6433440
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Colin S. Duckett
-
依托单位:
Inhibitor of Apoptosis (IAP) Gene Family
-
批准号:6558767
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Colin S. Duckett
-
依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
-
批准号:51976048
-
项目类别:面上项目
-
资助金额:61.0万元
-
批准年份:2019
-
负责人:邱朋华
-
依托单位: